"1|2" Pill Images
The following drug pill images match your search criteria.

1328
Amlodipine Besylate, Hydrochlorothiazide and Valsartan
- Strength
- 10 mg / 25 mg / 160 mg
- Imprint
- 1328
- Color
- Yellow
- Shape
- Capsule/Oblong

1325
Amlodipine Besylate, Hydrochlorothiazide and Valsartan
- Strength
- 10 mg / 25 mg / 320 mg
- Imprint
- 1325
- Color
- Yellow
- Shape
- Capsule/Oblong

NALFON 400 mg EP 123
Fenoprofen Calcium
- Strength
- 400 mg
- Imprint
- NALFON 400 mg EP 123
- Color
- Blue / Green
- Shape
- Capsule/Oblong
Featured

Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Reviews & ratings

V210
Virt-Vite Plus
- Strength
- Vitamin B Complex with C and Folic Acid
- Imprint
- V210
- Color
- White
- Shape
- Round

Lannett 1778 20 mg
Temozolomide
- Strength
- 20 mg
- Imprint
- Lannett 1778 20 mg
- Color
- Orange & White
- Shape
- Capsule/Oblong

322M 12.5/1000
Alogliptin Benzoate and Metformin Hydrochloride
- Strength
- 12.5 mg / 1000 mg
- Imprint
- 322M 12.5/1000
- Color
- Yellow
- Shape
- Oval

1382
Amlodipine Besylate, Hydrochlorothiazide and Olmesartan Medoxomil
- Strength
- 10 mg / 25 mg / 40 mg
- Imprint
- 1382
- Color
- Red
- Shape
- Oval

Logo 2510 Logo 2510
Aspirin and Extended-Release Dipyridamole
- Strength
- 25 mg / 200 mg
- Imprint
- Logo 2510 Logo 2510
- Color
- White
- Shape
- Capsule/Oblong

U4 12
Acetaminophen and Hydrocodone Bitartrate
- Strength
- 325 mg / 10 mg
- Imprint
- U4 12
- Color
- Yellow
- Shape
- Capsule/Oblong

102
Potassium Chloride Extended-Release
- Strength
- 8 mEq (600 mg)
- Imprint
- 102
- Color
- White
- Shape
- Capsule/Oblong
THER-RX 162
Niferex Gold
- Strength
- Vitamin B Complex with C, Folic Acid, Iron and Docusate
- Imprint
- THER-RX 162
- Color
- Orange
- Shape
- Oval

MYLAN MT 21 MYLAN MT 21
Memantine Hydrochloride Extended-Release
- Strength
- 21 mg
- Imprint
- MYLAN MT 21 MYLAN MT 21
- Color
- Green & White
- Shape
- Capsule/Oblong
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.